Fondazione Ricerca Traslazionale
Clinical trials sponsored by Fondazione Ricerca Traslazionale, explained in plain language.
-
Lung cancer patients get new hope with experimental combo therapy
Disease control OngoingThis study tests two drug combinations (Tedopi plus docetaxel or Tedopi plus nivolumab) as a second treatment option for people with advanced non-small-cell lung cancer whose cancer worsened after initial chemo-immunotherapy. About 105 adults with a specific genetic marker (HLA-A…
Phase: PHASE2 • Sponsor: Fondazione Ricerca Traslazionale • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New hope for lung cancer: combo therapy tested in phase 2 trial
Disease control OngoingThis study compares two treatments for people with advanced non-small-cell lung cancer that has spread. One group gets atezolizumab alone, the other gets atezolizumab plus bevacizumab. The goal is to see if the combination helps patients live longer and controls the cancer better…
Phase: PHASE2 • Sponsor: Fondazione Ricerca Traslazionale • Aim: Disease control
Last updated May 11, 2026 20:49 UTC